Related Experiment Video
Updated: Jul 17, 2026
10:01
Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
Human and murine obliterative bronchiolitis in transplant
1Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. jmcdyer@jhmi.edu
Proceedings of the American Thoracic Society
|January 5, 2007
Summary
Obliterative bronchiolitis significantly impacts lung transplant success. Animal models, like the tracheal allograft model, are crucial for understanding airway rejection mechanisms and developing new treatments.
Area of Science:
- Transplantation immunology
- Pulmonary medicine
Background:
- Obliterative bronchiolitis (OB) is a major cause of lung transplant failure.
- Current therapies for OB are largely ineffective, necessitating research into its pathogenesis.
Purpose of the Study:
- To review the utility of animal models, specifically the murine heterotopic tracheal allograft model, for studying OB.
- To compare the pathology observed in the tracheal allograft model with human OB and identify key mechanisms of airway rejection.
Main Methods:
- Review of existing literature on obliterative bronchiolitis and animal models.
- Comparison of human OB pathology with findings from the murine heterotopic tracheal allograft model.
- Analysis of mechanisms of airway rejection elucidated through the tracheal allograft model.
Main Results:
- The murine heterotopic tracheal allograft model mimics key aspects of human OB pathology.
- This model has been instrumental in describing critical mechanisms of airway rejection post-transplantation.
- Despite limitations, the model provides a platform for proof-of-concept studies.
Conclusions:
- Animal models, particularly the tracheal allograft model, are valuable tools for investigating OB pathogenesis.
- Translational studies using these models can inform human genetic and cellular research.
- A coordinated research network is needed to advance OB treatment and lung transplantation.
